trial
as of 2026-07-01FAAH Availability in Psychiatric Disorders: A PET Study
NCTId NCT04404712
at a glance
Early Phase 1 · Terminated
Enrollment 6 (actual)
Sponsored by Yale University
Primary completion 2021-06-30
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Early Phase 1
Status
Terminated
Enrollment
6 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2020-09-23
Primary completion
2021-06-30
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Sponsors
Yale UniversityLead Sponsor
Investigators
1
Mohini Ranganathan, MBBSPrincipal Investigator
Sites
1 total
New Haven, United States
Facts & assertions
4 sourced
Enrollment
6
Phase
EARLY_PHASE1
Primary Completion Date
2021-06-30
Status
TERMINATED
relationships
The graph out of here
drug
drug
lead_sponsor
company
indication
investigator
person